02/24/2019
Toral R. Patel, MD; Jerry Lipinski, BS; Petar Saric, MD; Sandeep M. Patel, MD; Angela Davis, RN; Alan H. Markowitz, MD; Hiram G. Bezerra, MD, PhD; Marco A. Costa, MD, PhD; Ankur Kalra, MD, FACP, FACC, FSCAI; Guilherme F. Attizzani, MD; Yasuhiro Ichibori, MD, PhD; Muhammad Siyab Panhwar, MD; Ghazanfar Qureshi, MD; Basar Sareyyupoglu, MD; David A. Zidar, MD, PhD; Jun Li, MD
Data on next-day discharge (NDD) after TAVR are limited. This study investigated the feasibility and safety of NDD as a first-line option compared with an early-discharge strategy after TAVR.
Data on next-day discharge (NDD) after TAVR are limited. This study investigated the feasibility and safety of NDD as a first-line option compared with an early-discharge strategy after TAVR.
Data on next-day discharge (NDD)...